InvestorsHub Logo
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: cheynew post# 202749

Thursday, 01/15/2015 11:09:38 AM

Thursday, January 15, 2015 11:09:38 AM

Post# of 345952
cheynew, it is true that CSM was scrutinized by the IHub PPHM board members only afther we learned the name from the PPHM communications related to the "3rd party CRO" as they named them in the beginning.

And I do indeed not see PPHM start to look into that detail into the individuals that make up the company given they will have operated under the assumption that if CSM is on the CRO list of the FDA the FDA did his jobs and will not allow people that would already have been involved with hanky-panky of clinicaltrials while at an other company to be part of it.

Yet we know that today CSM was involved, via JB, in such incident and the Finken took over the trial without taking the care to look back into what he received from JB when he took over (irresponsible, he didn't know what he took over and we all know what the consequences now are for PPHM) and yet he starts another company.

And he starts it with the co-patent holder of the labelling method, Schlecht ! (which buy the way means BAD in German and Dutch). So let's hope all together that the FDA doesn't grant them some "certification" related to CRO activities or sub-activities such as labelling.

But why am I under the impression the FDA might do just that?

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News